Povežite se z nami

testiranje na živalih

Veterinarska zdravila: zdaj veljajo nova pravila za spodbujanje zdravja živali in boj proti protimikrobni odpornosti

DELITI:

objavljeno

on

V boju proti protimikrobni odpornosti (AMR), prenovljena zakonodaja o zdravilih za uporabo v veterinarski medicini applies in the EU as from 28 January. Adopted three years ago, this legislation is now a cornerstone to support the achievement of the objectives set in the European One Health Action Plan and in the Farm to Fork Strategy against AMR. The legislation also consolidates the EU’s leading role on the global stage to act against AMR.

Pozdravlja ta mejnik, komisarka za zdravje in varnost hrane Stella Kyriakides made the following statement: “The COVID-19 pandemic has illustrated how human, plant and animal health, environmental health and food security are interlinked. The clearest illustration of these links is the silent pandemic of antimicrobial resistance.

“We have set an ambitious target in our Farm to Fork Strategy of halving overall EU sales of antimicrobials for farmed animals and in aquaculture by 2030. With the European One Health Action Plan, we aim to tackle this potential health crisis  by addressing human, animal and plant health as one continuum. The new rules will be key to achieving this.

“In the EU, the majority of antimicrobials are administered to animals, to which the same basic principle applies as for humans: to treat illness and keep them healthy. However, it is possible to reduce infections and the need for treatment in the first place, through improved hygiene practices and vaccination, as well as – in the case of farmed animals – biosecurity and animal husbandry. Limiting the use of antimicrobials must be the priority.

“The new rules will ensure that, as of today, treatments by antimicrobials for animals will be administered when, and only when, there is a real need for them. Together with the new legislation on medicated feed, which will ban the preventive use and restrict prescriptions of antimicrobial in medicated feed, the new rules will significantly strengthen the fights against AMR.  

“The new rules will also promote the availability of promising veterinary medicines in the future by stimulating innovation and competitiveness.

“I encourage all member states to make sure that the appropriate measures and resources are put in place, in order to ensure the full functioning of the legislation on the ground at national level, and to make its implementation a common success.

oglas

“The new rules strengthens the EU’s position is at the forefront of the global fight against AMR, while equipping us with a modern, innovative and fit-for-purpose legal framework on veterinary medicinal products.”

Ozadje

Veterinary medicines – also known as medicinal products for veterinary use, veterinary drugs or veterinary medicinal products (VMPs) – are substances or combinations of substances to treat, prevent or diagnose disease in animals.

EU podpira razvoj in odobritev varnih, učinkovitih in kakovostnih zdravil za uporabo v veterinarski medicini za proizvodnjo hrane in hišnih živali. Pomaga zagotavljati dostopnost teh zdravil in hkrati zagotavlja najvišjo raven javnega zdravja, zdravja živali in varstva okolja.

Sprejeto leta 2019, nova Uredba o veterinarskih zdravilih (VMPs) začne veljati 28. januarja 2022.

Glavni cilji zakonodaje so:

  • Vzpostaviti sodoben, inovativen in namenu primeren pravni okvir;
  • spodbujati inovacije za VMP in povečati njihovo razpoložljivost ter;
  • okrepiti boj EU proti protimikrobni odpornosti.

V zadnjih letih si je Komisija prizadevala za sprejetje približno 25 delegiranih in izvedbenih aktov za dopolnitev te uredbe, od tega polovica do datuma začetka uporabe uredbe.

Več informacij

Vprašanja in odgovori

Delite ta članek:

EU Reporter objavlja članke iz različnih zunanjih virov, ki izražajo širok razpon stališč. Stališča v teh člankih niso nujno stališča EU Reporterja.

Trendi